{"cik":1872356,"taxonomy":"us-gaap","tag":"OperatingLeaseRightOfUseAsset","label":"Operating Lease, Right-of-Use Asset","description":"Amount of lessee's right to use underlying asset under operating lease.","entityName":"Molekule Group, Inc.","units":{"USD":[{"end":"2022-12-31","val":1606485,"accn":"0001558370-23-005327","fy":2022,"fp":"FY","form":"10-K","filed":"2023-03-31"},{"end":"2022-12-31","val":1606485,"accn":"0001558370-23-005401","fy":2022,"fp":"FY","form":"10-K/A","filed":"2023-04-03"},{"end":"2022-12-31","val":1606485,"accn":"0001558370-23-009975","fy":2023,"fp":"Q1","form":"10-Q","filed":"2023-05-15"},{"end":"2022-12-31","val":1606485,"accn":"0001558370-23-014929","fy":2023,"fp":"Q2","form":"10-Q","filed":"2023-08-14","frame":"CY2022Q4I"},{"end":"2023-03-31","val":10822618,"accn":"0001558370-23-009975","fy":2023,"fp":"Q1","form":"10-Q","filed":"2023-05-15","frame":"CY2023Q1I"},{"end":"2023-06-30","val":10952143,"accn":"0001558370-23-014929","fy":2023,"fp":"Q2","form":"10-Q","filed":"2023-08-14","frame":"CY2023Q2I"}]}}